1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
PharmChem, Inc.

PharmChem, Inc.

PCHM
PharmChem, Inc.US flagOther OTC
3.75
USD
+0.01
- -
21.95MMarket Cap
1990 Y
1991 Y
1992 Y
1993 Y
1994 Y
1995 Y
1996 Y
1997 Y
1998 Y
1999 Y
2000 Y
2001 Y
2002 Y
TTM
Revenue per Share
3.49
4.68
4.65
5.21
6.72
7.07
7.23
6.63
7.92
7.69
6.77
6.25
5.14
4.72
Basic EPS, GAAP
0.09
0.33
0.39
-0.7
0.02
-1.23
0.01
-0.22
0.11
0.48
0.23
-1.45
0.57
-0.17
Free Cash Flow per Basic Share
0.09
0.23
0.44
-0.31
0.02
0.34
- -
-0.25
0.31
0.07
-0.15
-1.71
-0.04
-0.22
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.23
0.14
0.49
-0.16
-0.18
-1.39
1.98
4.73
1.98
2.36
-0.7
-2.15
-1.58
-1.75
Tangible Book Value per Share
1.13
3.98
2.2
1.78
2.4
1.36
1.39
1.17
1.45
1.88
2.13
1.03
1.65
1.47
Basic Weighted Avg Shares
4
5
6
6
5
6
6
6
5
6
6
6
6
6
Sales/Revenue/Turnover
16
24
27
29
34
39
41
39
43
44
39
37
30
28
Operating Margin (%)
9.68
15.35
13.5
-1.38
1.49
1.28
1.01
-2.55
2.78
6.19
2.02
-22.15
-2.6
-4.05
Depreciation Expense
-1
-1
-2
-2
-3
-3
2
-2
-2
2
2
2
2
2
Net Income, GAAP
- -
2
2
-4
- -
-7
- -
-1
1
3
1
-8
3
-1
Effective Tax Rate (%)
50
39.29
37.84
- -
50
- -
- -
- -
33.33
- -
47.31
- -
- -
- -
Profit Margin (%)
2.58
7.05
8.39
-13.45
0.3
-17.39
0.11
-3.32
1.39
6.29
3.45
-23.18
11.11
-3.58
Working Capital
3
17
8
4
4
4
2
-1
- -
3
2
-6
-2
1
LT Debt
1
2
3
2
2
3
1
1
1
3
2
3
1
4
Total Equity
7
22
22
18
18
11
11
10
11
14
15
7
10
9
Return on Invested Capital (%)
8.2
12.99
8.61
- -
1.03
- -
2.75
- -
5.37
- -
2.3
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
127.78
- -
- -
- -
- -
-6.63
3.1
22.88
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'03
Jun'03
Sep'03
ST Debt
5
2
1
LT Borrowings
1
4
4
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
6
Market Capitalization
1
1
3

Working Capital

FRC

•

in mil. unless spec.
Mar'03
Jun'03
Sep'03
Total Current Assets
8
8
7
Cash, Cash Equivalents & STI
3
2
2
Accounts Receivable, Net
4
4
4
Inventories
1
1
1
Total Current Liabilities
11
7
6
Payables & Accruals
5
5
4
ST Debt
5
2
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-2.19%
8.35%
53.74%
Free Cash Flow
-391.06%
62.96%
-97.61%
Net Income, GAAP
-1,099.2%
-138.62%
-139.43%
Sales/Revenue/Turnover
1.54%
-4.63%
-17.72%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available

Company Description

MCPAPIChat
CEO
Thompson Clark CPA
Full Time Employees
9
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Address
2411 East Loop 820 North Fort Worth TX United States of America 76118
IPO Date
Jan 8, 2021
Website
pharmchek.com
Similar Companies
Tecan Group AG (TCHBF)
23andMe Holding Co. (ME)
Global Cord Blood Corporation (CO)
Labcorp Holdings Inc. (0JSY.L)
Global WholeHealth Partners Corporation (GWHP)
Vimian Group AB (publ) (VIMGF)
Business
PharmChem, Inc., now operating as part of Alcohol Monitoring Systems, Inc. (SCRAM Systems), specializes in advanced drug testing solutions. Its core offering, the FDA-cleared PharmChek® Drugs of Abuse Sweat Patch, provides continuous, tamper-evident monitoring for a wide range of illicit substances, encompassing cannabis, cocaine, opiates, amphetamines, PCP, fentanyl, and various other drugs and their metabolites. This Fort Worth, Texas-based entity offers a reliable, non-invasive alternative to traditional urine testing, serving the needs of the criminal justice system, child welfare, and other monitoring programs with its extended detection capabilities.

Company News

MCPAPIChat

  • prnewswire.com

    PharmChem, Inc. Announces Shareholder Approval of Acquisition by Alcohol Monitoring Systems, Inc.

  • businesswire.com

    Shareholder Alert: The Ademi Firm Investigates Whether PharmChem, Inc. is Obtaining a Fair Price for its Public Shareholders

  • prnewswire.com

    Shareholder Alert: The Ademi Firm investigates whether PharmChem, Inc. is obtaining a Fair Price for its Public Shareholders

  • prnewswire.com

    PharmChem, Inc. Announces Acquisition by Alcohol Monitoring Systems, Inc.

  • prnewswire.com

    PharmChem, Inc. Announces Exploration of Strategic Alternatives